Exor NV
AEX:EXO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
86.28
105.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Exor NV
Total Equity
Exor NV
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Exor NV
AEX:EXO
|
Total Equity
€38.3B
|
CAGR 3-Years
37%
|
CAGR 5-Years
22%
|
CAGR 10-Years
18%
|
Exor NV
Glance View
Exor NV, a powerhouse in the world of international investment, traces its roots back to the illustrious Agnelli family, renowned for establishing Fiat in 1899. Today, Exor stands as a modern-day conglomerate, headquartered in Amsterdam, but operating with a distinctly global reach. The company has diversified well beyond its automotive origins, reflecting a shrewd investment approach characterized by deep value and long-term growth. The firm's portfolio is an eclectic mix of industry giants and significant holdings, encompassing automotive stalwarts like Stellantis, luxury brands such as Ferrari, and investments in media through companies like The Economist Group. This wide-ranging portfolio illustrates Exor’s strategic knack for spotting opportunities that align with its disciplined investment philosophy, often allowing it to hold considerable sway over the companies it invests in. Exor’s business model revolves around actively managing and strategically allocating capital to optimize value across its varied interests. The company essentially operates as an investment fund with a long-term horizon, generating revenue through dividends, capital gains, and whatever synergies might be derived from its cross-sector holdings. By leveraging its substantial equity stakes, Exor can influence management and operations to enhance the performance of its investments. This hands-on approach, coupled with a keen eye for potential and patience for investments to mature, underscores how Exor expertly navigates diverse industries to yield robust financial returns. The company’s success lies in its adept balance of innovation and tradition, always seeking sustainable growth while remaining anchored to its foundational philosophies.
See Also
What is Exor NV's Total Equity?
Total Equity
38.3B
EUR
Based on the financial report for Jun 30, 2024, Exor NV's Total Equity amounts to 38.3B EUR.
What is Exor NV's Total Equity growth rate?
Total Equity CAGR 10Y
18%
Over the last year, the Total Equity growth was 73%. The average annual Total Equity growth rates for Exor NV have been 37% over the past three years , 22% over the past five years , and 18% over the past ten years .